Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.
about
Epigenetic regulation of Keap1-Nrf2 signalingCytoprotection "gone astray": Nrf2 and its role in cancerModeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.Targeting nrf2 signaling to combat chemoresistance.Methylglyoxal induces endoplasmic reticulum stress and DNA demethylation in the Keap1 promoter of human lens epithelial cells and age-related cataracts.Keap1 expression has independent prognostic value in pancreatic adenocarcinomasFunctional Role of NRF2 in Cervical Carcinogenesis.UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesisBRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.Endoplasmic reticulum stress, genome damage, and cancer.Nrf2 activation as target to implement therapeutic treatmentsSIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy.Ubiquitin ligases in oncogenic transformation and cancer therapy.The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy.Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
P2860
Q28084220-B461E793-F115-4989-9CB7-C7EE29E4EFAEQ28393784-4DF89125-24F3-4A18-8270-834F7AE3528FQ34234101-1F072D4B-DA46-4722-A0A8-B01E1E168207Q34376139-72E77B70-2FD6-427E-B22E-C397F75163E9Q35542218-D56AC61A-41C7-4B0F-B9BD-6950F8808088Q35576302-3960794B-06D6-4947-8465-E4A8E8118C6DQ35738532-71D7A2AB-83CB-484E-A3C6-0AFEEA671549Q36536562-B1533827-9E97-4BC5-825E-712DEB348F40Q37055527-D68D212F-0DFB-42DF-B4B6-FDA7C1A12703Q37706890-197EFAC2-AD96-4A66-B7D5-1580720B5333Q38359856-0DF0A529-ADCB-4DF6-AF29-D207CBD0728AQ38362698-7B5F6F6F-5D7E-4EEC-861A-EF7EBB006879Q38896426-2C9F97D2-6BF1-4987-9FDF-537C363D65DBQ38993234-AEF4771B-27DB-443C-BEFF-F7430C6D6D89Q41328173-ED422435-BACB-459C-9977-59191AEC59B6Q41678966-BBD3F284-17C7-45AE-8452-C70D12C1720DQ46609299-F5FD2136-076B-4ED6-ACD3-FE5F9D5A3409Q48214395-DC619711-B87A-43B4-A672-D9E8CDE057E0Q53693403-AFD59CF2-6599-4CB0-AB7A-A545E0393C60Q53696229-7C289461-3872-4B6E-A7E1-3C34306BC51E
P2860
Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Aberrant Keap1 methylation in ...... clinicopathological features.
@ast
Aberrant Keap1 methylation in ...... clinicopathological features.
@en
type
label
Aberrant Keap1 methylation in ...... clinicopathological features.
@ast
Aberrant Keap1 methylation in ...... clinicopathological features.
@en
prefLabel
Aberrant Keap1 methylation in ...... clinicopathological features.
@ast
Aberrant Keap1 methylation in ...... clinicopathological features.
@en
P2093
P2860
P356
P1433
P1476
Aberrant Keap1 methylation in ...... clinicopathological features.
@en
P2093
Andrea Fontana
Annamaria la Torre
Barbara Pasculli
Evaristo Maiello
Fabio Pellegrini
Giovanni Francesco Marangi
Lucia Anna Muscarella
Maria Luana Poeta
Marina Castelvetere
Michelina Coco
P2860
P304
P356
10.4161/EPI.23319
P577
2012-12-18T00:00:00Z